Focus on:  Hide Contributions
Login

Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024

18–19 Oct 2024
Zoom
Europe/Zurich timezone

Contribution List

52 out of 52 displayed
Export to PDF
  1. 82. Participants registration
    18/10/2024, 08:00
  2. 83. Welcome Addresses
    18/10/2024, 08:45

    Maria Bigaki (IAEA CP, Papageorgiou), Michail Karaviotis ( Papageorgiou),
    Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO),
    Panagiotis Bamidis (AUTH,/AHEPA, ELEVIT)

    Go to contribution page
  3. 84. Historic and scientific evolution of Hadron Therapy
    Ugo Amaldi (TERA Foundation (IT)), Sandro Rossi (CNAO)
    18/10/2024, 09:15
  4. 85. Hadron Therapy in clinical practice
    Sara Lillo (CNAO)
    18/10/2024, 09:35
  5. 86. Radiobiology of Hadron Therapy
    Angelica Facoetti (CNAO)
    18/10/2024, 09:55
  6. 87. HITRIplus project, its impact on boosting research in South East Europe and future perspectives
    Sanja Damjanovic (SEEIIST Association (CH) / GSI)
    18/10/2024, 10:15
  7. 88. Building capacity through the IAEA programs
    Sotirios Charisopoulos (IAEA)
    18/10/2024, 10:35
  8. 90. Hadron Therapy : from pioneering times towards the future
    Manjit Dosanjh (University of Oxford (GB))
    18/10/2024, 11:30
  9. 93. SEEIIST facility design and alternatives
    Maurizio Vretenar (CERN)
    18/10/2024, 11:50
  10. 95. CERN as an example of large scale infrastructure
    Emmanuel Tsesmelis (CERN)
    18/10/2024, 12:10
  11. 97. Status and vision of the SEEIIST project
    Leandar Litov (University of Sofia - St. Kliment Ohridski (BG))
    18/10/2024, 12:30
  12. 101. Concluding remarks
    Roberto Orecchia (IEO)
    18/10/2024, 12:50
  13. 100. Round table – SEEIIST towards to the Future
    18/10/2024, 13:00

    Moderators: Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO)
    Panelists: Maurizio Vretenar (CERN), Semi Harrabi (HIT)
    Contributions: Introduction, cancer incidence in SEE Mimoza Ristova (Uni Skopje)

    Go to contribution page
  14. 105. Hadron Therapy at GSI - where we come from, where we go
    Konrad Lehmann (GSI)
    18/10/2024, 15:00
  15. 106. The HIT facility, technology, clinical applications and research: novel approaches in particle therapy
    Andrea Mairani (HIT)
    18/10/2024, 15:25
  16. 112. The Krakow Hadron Therapy facility, lessons learnt
    Pawel Olko (IFJ - PAN)
    18/10/2024, 15:50
  17. 127. Concluding remarks
    Angelica Facoetti (CNAO)
    18/10/2024, 16:15
  18. 115. Accelerator and beam physics developments for medical and societal applications at CERN
    Alessandra Lombardi (CERN)
    18/10/2024, 17:00
  19. 118. Innovative gantry designs: Superconducting magnets for advanced gantry
    Ernesto De Matteis (INFN)
    18/10/2024, 17:20
  20. 136. Innovative gantry designs-continued
    Ariel Haziot (CERN)
    18/10/2024, 17:35
  21. 116. Optimisation for pre-injectors for hadron therapy-AM
    Aristeidis Mamaras (Aristotle University of Thessaloniki / CERN)
    18/10/2024, 17:50
  22. 119. An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-Herzegovina
    Amer Ajanovic (CERN/UNSA), Danis Bradaric (UNSA), Medina Dugonjic (UNSA), Naida Ustavdic (UNSA)
    18/10/2024, 18:10
  23. 138. Development of the first table-top X-ray FLASH system
    Ms ELPIDA THEODORIDOU (DKFZ / Uni Malta), Joao Seco (DKFZ)
    18/10/2024, 18:25
  24. 124. Concluding remarks
    Laura Vallow (Mayo Clinic)
    18/10/2024, 18:40
  25. 126. Welcome, Music event and Welcome Drink
    18/10/2024, 20:00

    Concert and Welcome Drink

    Go to contribution page
  26. 91. Chordoma treatments at CNAO
    Maria Rosaria Fiore (CNAO)
    19/10/2024, 09:00
  27. 92. Sarcoma treatments in Greece
    Tasos Kyriazoglou (Attikon University Hospital)
    19/10/2024, 09:25
  28. 94. Radiosurgery for Skullbase Meningiom
    Christos Boskos (ST. LUKE'S)
    19/10/2024, 09:45
  29. 96. SRS Treatment Planning for Endocranial Tumor
    Anna Makridou
    19/10/2024, 10:05
  30. 98. Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerability
    Michael Story (Mayo Clinic)
    19/10/2024, 10:25
  31. 99. Concluding remarks
    Arnold Pompos (UT Southwestern, Dallas, TX), Joao Seco (DKFZ)
    19/10/2024, 10:50
  32. 102. Hadrontherapy and EU clinical networks: status and perspectives
    Lisa Licitra (CNAO, Uni Milan)
    19/10/2024, 11:30
  33. 103. Costs of hadrontherapy, the ABC analysis applied to operations in CNAO
    Maria Vittoria Livraga (CNAO)
    19/10/2024, 11:50
  34. 104. Caring for cancer patients: the CNAO social approach
    Silvia Meneghello (CNAO)
    19/10/2024, 12:10
  35. 107. The role of citizens in innovating health
    Katerina Zourou (Web2Learn), Stefania Oikonomou (Web2Learn)
    19/10/2024, 12:30
  36. 110. The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level
    Alkinoos Athanasiou (AUTH, ELEVIT)
    19/10/2024, 12:45
  37. 111. Challenges and Opportunities in the Patient's Pathway to Access
    Menia Koukougianni (NGO KARKINAKI)
    19/10/2024, 13:00
  38. 108. Empowering patient advocacy and cancer prevention
    Panagiotis Bamidis (AUTH/AHEPA, ELEVIT)
    19/10/2024, 13:20
  39. 113. Concluding remarks
    Sandro Rossi (CNAO)
    19/10/2024, 13:35
  40. 128. Carbon Programme in MedAustron
    Piero Fossati (MedAustron)
    19/10/2024, 15:00
  41. 129. Pediatric Treatments in MedAustron
    Carola Lütgendorf-Caucig (MedAustron)
    19/10/2024, 15:15
  42. 117. Hadron therapy state-of-the art in pediatric oncology-clinical aspects
    Sabina Vennarini (CNAO)
    19/10/2024, 15:30
  43. 120. Treatment planning for pediatric cancer tumour treatments
    Alfredo Mirandola (CNAO)
    19/10/2024, 15:45
  44. 130. Pediatric brain tumour surgery : where do we stand?
    Nikos Foroglou (AUTH/AHEPA)
    19/10/2024, 16:00
  45. 131. Role of surgery in pediatric soft tissue sarcoma
    Aikaterini Tzantzaroudi (Hippokration Hospital)
    19/10/2024, 16:15
  46. 125. Panel discussion: Paediatric Oncology in Greece
    19/10/2024, 17:00
  47. 132. Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPA
    Emmanouel Chatzipantelis (AUTH/AHEPA)
    19/10/2024, 17:01
  48. 133. Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio Hospital
    Evgenia Papakonstantinou (Hippokrateio Hospital)
    19/10/2024, 17:15
  49. 123. Pediatric patients commonly referred for external beam Radiotherapy
    Antonio Capizzello (AUTH / AHEPA), Eftychia Tataridou (Theageneio Hospital)
    19/10/2024, 17:30
  50. 121. The spectrum of pediatric patients referred for Protontherapy
    Barbara Rombi (APSS - TRENTO)
    19/10/2024, 17:45
  51. 134. Radiation treatment plan for pediatric cancer: a clinical view
    George Giakoumetis (AUTH/AHEPA)
    19/10/2024, 18:00
  52. 135. Concluding remarks
    Semi Harrabi (HIT)
    19/10/2024, 18:15

Back to the event